학술논문
Efficacy on the risk of vertebral fracture with administration of once-weekly 17.5 mg risedronate in Japanese patients of established osteoporosis with prevalent vertebral fractures: a 156-week longitudinal observational study in daily practice
Document Type
Article
Author
Source
In: Journal of Bone and Mineral Metabolism . (Journal of Bone and Mineral Metabolism, 1 July 2017, 35(4):419-427)
Subject
Language
English
ISSN
14355604
09148779
09148779